The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7829737 B1

PDF
Full Text
Expired
Date of Patent:
Nov. 09, 2010

Filed:

Mar. 06, 2008
Applicants:

Mark Arnold Thomas Blaskovich, Bardon, AU;

Ted Baughman, Bothell, WA (US);

Thomas Little, Redmond, WA (US);

Maher Qabar, Sammamish, WA (US);

Lauri Marie Schultz, Batavia, WA (US);

Feng Hong, Bellevue, WA (US);

William Patt, Lawrence, KS (US);

Gangadhar Nagula, Bothell, WA (US);

Jennifer Lynn Gage, Kenmore, WA (US);

James Jeffry Howbert, Bellevue, WA (US);

Inventors:

Mark Arnold Thomas Blaskovich, Bardon, AU;

Ted Baughman, Bothell, WA (US);

Thomas Little, Redmond, WA (US);

Maher Qabar, Sammamish, WA (US);

Lauri Marie Schultz, Batavia, WA (US);

Feng Hong, Bellevue, WA (US);

William Patt, Lawrence, KS (US);

Gangadhar Nagula, Bothell, WA (US);

Jennifer Lynn Gage, Kenmore, WA (US);

James Jeffry Howbert, Bellevue, WA (US);

Assignee:

Ceptyr, Inc., Bothell, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 9/02 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides compounds of Formula (I) and Formula (II) that are useful for modulating the biological activity of the protein tyrosine phosphatase-1b (PTP1B) enzyme. Compounds of this invention can be used to treat diseases and/or conditions in which the PTP1B enzyme is a factor. Such diseases and/or conditions include, but are not limited to, Type 1 diabetes, Type 2 diabetes, inadequate glucose tolerance, insulin resistance, obesity, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL levels, atherosclerosis, vascular restenosis, inflammatory bowel disease, pancreatitis, adipose cell tumors, adipose cell carcinoma, liposarcoma, dyslipidemia, cancer, and neurodegenerative diseases.


Find Patent Forward Citations

Blaskovich, Mark Arnold Thomas. (2010). Protein tyrosine phosphatase inhibitors and methods of use thereof (U.S. Patent No. 7829737). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7829737

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…